Norway· NO-ID_3A27D444-573E-456F-93A5-358720C85C68

Ryeqo

A relugolix, estradiol und norethisteron product containing norethisterone acetate + estradiol + relugolix, registered in Norway by Gedeon Richter Plc.. The same ATC class is registered in 11 of our 19 countries.

ATC H01CC54

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedRyeqoATCH01CC54REGISTER NO.NO-ID_3A27D444-573E-4…PACKS LISTED9CHECKEDSeptember 25, 2026

Where it is registered

Relugolix, estradiol und norethisteron is registered in 11 of 19 countries.

Countries holding a registration under ATC H01CC54 (relugolix, estradiol und norethisteron), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 7 of them publish a price we can compare per daily dose

Relugolix, estradiol und norethisteron · ATC H01CC54

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FEST (Norway)
Active substance
Norethisterone Acetate + Estradiol + Relugolix
Manufacturer
Gedeon Richter Plc.
Country
Norway (NO)
ATC code
H01CC54
ATC class
Relugolix, Estradiol und Norethisteron
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 9

4 priced
  • no_varenummer
    198638
    28
    NOK 1182.8
  • no_varenummer
    565815
    28
    NOK 1182.8
  • no_varenummer
    499449
    84
    NOK 3409.6
  • gtin
    5997001371787
  • gtin
    5997001377963
  • gtin
    5997001371800
  • gtin
    5997001377970
  • no_merkevare_id
    ID_3A27D444-573E-456F-93A5-358720C85C68
  • no_varenummer
    456735
    3 x 28
    NOK 3409.6

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Relugolix, estradiol und norethisteron in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All relugolix, estradiol und norethisteron products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Iceland · Ryeqo
  • Liechtenstein · Ryeqo

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f1e80a1d-9a94-4d63-96a3-4f74663941ae
GET /v1/drugs/f1e80a1d-9a94-4d63-96a3-4f74663941ae?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablett, filmdrasjert",
  "source": "fest",
  "status": "A",
  "atc_name": "Relugoliks, østradiol og noretisteron",
  "merkevare_id": "ID_3A27D444-573E-456F-93A5-358720C85C68",
  "name_form_strength": "Ryeqo tab 40 mg/1 mg/0,5 mg",
  "prescription_group": "C"
}

See everything about relugolix, estradiol und norethisteron.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.